n-benzyloxycarbonylprolylprolinal has been researched along with lithium carbonate in 1 studies
| Studies (n-benzyloxycarbonylprolylprolinal) | Trials (n-benzyloxycarbonylprolylprolinal) | Recent Studies (post-2010) (n-benzyloxycarbonylprolylprolinal) | Studies (lithium carbonate) | Trials (lithium carbonate) | Recent Studies (post-2010) (lithium carbonate) |
|---|---|---|---|---|---|
| 39 | 0 | 7 | 2,964 | 394 | 379 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breen, G; Collier, D; Gregory, K; Harwood, AJ; Sinclair, M; St Clair, D; Williams, RS | 1 |
1 other study(ies) available for n-benzyloxycarbonylprolylprolinal and lithium carbonate
| Article | Year |
|---|---|
Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients.
Topics: Antipsychotic Agents; Bipolar Disorder; Dipeptides; Humans; Lithium Carbonate; Neurons; Prolyl Oligopeptidases; Schizophrenia; Serine Endopeptidases | 2004 |